Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07222475
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 11 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Songwriting intervention (active music therapy) — BEHAVIORALParticipants will engage in a songwriting intervention with a music therapist.
Study Details
This research aims to see if songwriting can help reduce anxiety in adolescents with Sickle Cell Disease. The purpose of the study is to discover if participants find songwriting and playing their songs to be practical and acceptable, and helpful for managing anxiety.
Key Dates
- Start date
- Feb 5, 2026
- Status verified
- Feb 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Active Music TherapySongwriting intervention
Primary Outcome Measure
Change in State-Trait Anxiety Inventory score [ Time Frame: Baseline, 3 months ]
Central Contacts
- Pam Peterson507-422-5523
- C. Robert Bennett
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Division of Nursing | Rochester | Minnesota | 55905 | Pam Peterson 507-422-5523 |
Find similar trials in Rochester, MN
By condition
By research site
Related Studies
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting · American Thrombosis and Hemostasis Network · Phoenix, Arizona
- Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene TherapyEnrolling By Invitation · Genetix Biotherapeutics Inc. · Birmingham, Alabama
- A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301Enrolling By Invitation · Editas Medicine, Inc. · Oakland, California
- A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell DiseasePHASE3 · Recruiting · Novo Nordisk A/S · Birmingham, Alabama